ADAGE Capital Partners Gp, LLC, 10% Owner at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 315,444 shares at $79.19 ($25.2M) on 2017-06-12, disclosed to the SEC on 2017-06-12.
Open-market sale of $25.2M PBYI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.49 | 10,462 | $853K | 3.4% |
| 2 | $81.49 | 10,462 | $853K | 3.4% |
| 3 | $80.41 | 34,206 | $2.8M | 10.9% |
| 4 | $80.41 | 34,206 | $2.8M | 10.9% |
| 5 | $81.29 | 24,110 | $2.0M | 7.8% |
| 6 | $81.29 | 24,110 |
| $2.0M |
| 7.8% |
| 7 | $79.19 | 77,247 | $6.1M | 24.2% |
| 8 | $79.19 | 77,247 | $6.1M | 24.2% |
| 9 | $80.08 | 11,697 | $937K | 3.7% |
| 10 | $80.08 | 11,697 | $937K | 3.7% |
| Total | $79.99 avg | 315,444 | $25.2M | 100% |
| Filing → |
| GCMG | BUY | 2021-07-13 | $4.3M | — | Filing → |
| GCMG | SELL | 2021-07-13 | $8.6M | — | Filing → |
| GCMG | SELL | 2021-07-13 | $1.5M | — | Filing → |